Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002343064 | SCV002644515 | uncertain significance | Cardiovascular phenotype | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.-4T>A variant is located in the 5' untranslated region (5’ UTR) of the JPH2 gene. This variant results from a T to A substitution 4 bases upstream from the first translated codon. This nucleotide position is well conserved in available vertebrate species. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003331352 | SCV004038210 | uncertain significance | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005051962 | SCV005685852 | uncertain significance | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Located in the 3' untranslated region (UTR); in the absence of functional studies, the actual effect of this sequence change is unknown; No regulatory variants in the JPH2 gene have been reported in HGMD in association with JPH2-related disorders (HGMD) |